Efficacy of topical tofacitinib, a Janus kinase inhibitor, in the treatment of plaque psoriasis

被引：6
|
作者：
Bagherani, Nooshin [1 ]
Smoller, Bruce R. [2 ]
机构：
[1] Dr Nooshin Bagherans Off, Khoramshahr, Khuzestan Provi, Iran
[2] Univ Rochester, Sch Med & Dent, Dept Dermatol, Dept Pathol, Rochester, NY 14642 USA
来源：
DERMATOLOGIC THERAPY | 2017年 / 30卷 / 03期
关键词：
psoriasis; tofacitinib; treatment; CLINICAL-TRIAL;
D O I：
10.1111/dth.12467
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] REESTABLISHMENT OF EFFICACY OF TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN RHEUMATOID ARTHRITIS PATIENTS AFTER TEMPORARY DISCONTINUATION
    Kaine, J.
    Tesser, J.
    DeMasi, R.
    Takiya, L.
    Wang, L.
    Snyder, M.
    Fan, H.
    Wollenhaupt, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 275 - 276
  • [42] Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)
    Yokoyama, Seiji
    Perera, Pin-Yu
    Terawaki, Seigo
    Watanabe, Nobumasa
    Kaminuma, Osamu
    Waldmann, Thomas A.
    Hiroi, Takachika
    Perera, Liyanage P.
    JOURNAL OF CLINICAL IMMUNOLOGY, 2015, 35 (07) : 661 - 667
  • [43] Janus Kinase Inhibitor Tofacitinib Shows Potent Efficacy in a Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)
    Seiji Yokoyama
    Pin-Yu Perera
    Seigo Terawaki
    Nobumasa Watanabe
    Osamu Kaminuma
    Thomas A. Waldmann
    Takachika Hiroi
    Liyanage P. Perera
    Journal of Clinical Immunology, 2015, 35 : 661 - 667
  • [44] Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population
    Stephen Hall
    Peter Nash
    Maureen Rischmueller
    David Bossingham
    Paul Bird
    Nicola Cook
    David Witcombe
    Koshika Soma
    Kenneth Kwok
    Krishan Thirunavukkarasu
    Rheumatology and Therapy, 2018, 5 : 383 - 401
  • [45] Effect of the Janus kinase inhibitor tofacitinib in the treatment of juvenile scleroderma: A single-center experience
    Colussi, Lara
    Dagri, Arianna
    Pastore, Serena
    Tommasini, Alberto
    Pin, Alessia
    Taddio, Andrea
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (08)
  • [46] Treatment of severe alopecia areata with the oral Janus kinase inhibitor, tofacitinib: A retrospective chart review
    Ibrahim, O.
    Hogan, S.
    Piliang, M.
    Bergfeld, W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (05) : S65 - S65
  • [47] Efficacy and safety of tofacitinib for the treatment of chronic plaque psoriasis: a systematic review and meta-analysis
    Tian, Fangyuan
    Chen, Zhaoyan
    Xu, Ting
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (06) : 2342 - 2350
  • [48] The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans
    Dowty, Martin E.
    Lin, Jinyan
    Ryder, Tim F.
    Wang, Weiwei
    Walker, Gregory S.
    Vaz, Alfin
    Chan, Gary L.
    Krishnaswami, Sriram
    Prakash, Chandra
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (04) : 759 - 773
  • [49] Concurrent bullous pemphigoid and psoriasis vulgaris successfully treated with Janus kinase inhibitor tofacitinib: A case report and review of the literature
    Li, Hongda
    Wang, Honglei
    Qiao, Guizhi
    Liu, Yongxia
    Zhang, Furen
    Pan, Futang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [50] Effects of Diabetes Mellitus on the Disposition of Tofacitinib, a Janus Kinase Inhibitor, in Rats
    Gwak, Eun Hye
    Yoo, Hee Young
    Kim, So Hee
    BIOMOLECULES & THERAPEUTICS, 2020, 28 (04) : 361 - 369
12345